Perflutren (** Definity (generic: perflutren lipid microsphere) **)
Other Medications
Description
Perflutren is not used in the treatment of colorectal cancer. It is primarily utilized for diagnostic purposes to enhance ultrasound imaging, particularly in cardiology and echocardiography contexts.
Mechanism of Action
Perflutren is a contrast agent used in ultrasound imaging, not an anticancer drug; it consists of perfluorocarbon lipid microspheres that enhance the visibility of blood flow and tissue structures.
Side Effects
Hypersensitivity reactions; pulmonary edema; cardiovascular effects such as arrhythmias and hypotension
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT01631318
Not Applicable
Archived
Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases
United States